These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9011596)

  • 1. Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta.
    Sowade O; Gross J; Sowade B; Warnke H; Franke W; Messinger D; Scigalla P; Lun A; Glatzel E
    J Lab Clin Med; 1997 Jan; 129(1):97-105. PubMed ID: 9011596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery.
    Sowade O; Warnke H; Scigalla P; Sowade B; Franke W; Messinger D; Gross J
    Blood; 1997 Jan; 89(2):411-8. PubMed ID: 9002942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery.
    Sowade O; Ziemer S; Sowade B; Franke W; Messinger D; Ziebell E; Scigalla P; Warnke H
    J Lab Clin Med; 1997 Mar; 129(3):376-83. PubMed ID: 9042823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients.
    Sowade O; Sowade B; Brilla K; Franke W; Stephan P; Gross J; Scigalla P; Warnke H
    Am J Hematol; 1997 Jun; 55(2):89-96. PubMed ID: 9209004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery.
    Sowade O; Messinger D; Franke W; Sowade B; Scigalla P; Warnke H
    Eur J Haematol; 1998 Apr; 60(4):252-9. PubMed ID: 9579879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
    Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
    Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oxygen status of the arterial blood in the critically ill.
    Tulli G; Vignali G; Guadagnucci A; Mondello V
    Scand J Clin Lab Invest Suppl; 1990; 203():107-18. PubMed ID: 2128553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma.
    Kettelhack C; Hönes C; Messinger D; Schlag PM
    Br J Surg; 1998 Jan; 85(1):63-7. PubMed ID: 9462386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.
    Osterborg A; Brandberg Y; Molostova V; Iosava G; Abdulkadyrov K; Hedenus M; Messinger D;
    J Clin Oncol; 2002 May; 20(10):2486-94. PubMed ID: 12011126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of Epoetin alfa in complex spine deformity surgery.
    Shapiro GS; Boachie-Adjei O; Dhawlikar SH; Maier LS
    Spine (Phila Pa 1976); 2002 Sep; 27(18):2067-71. PubMed ID: 12634571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery--prospective double-blind placebo-controlled study.
    Qvist N; Boesby S; Wolff B; Hansen CP
    World J Surg; 1999 Jan; 23(1):30-5. PubMed ID: 9841760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
    Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
    Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new protocol of iron therapy combined with epoetin alpha as a treatment for preoperative autologous blood donation in gynaecological tumor surgery.
    Gargano G; Fanizza G; Polignano G; Lorusso V; De Lena M
    Oncol Rep; 1999; 6(6):1349-52. PubMed ID: 10523710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.
    Feagan BG; Wong CJ; Kirkley A; Johnston DW; Smith FC; Whitsitt P; Wheeler SL; Lau CY
    Ann Intern Med; 2000 Dec; 133(11):845-54. PubMed ID: 11103054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients.
    Mantovani G; Ghiani M; Curreli L; Maccio A; Massa D; Succu G; Lai P; Massa E; Mudu MC; Astara G
    Oncol Rep; 1999; 6(2):421-6. PubMed ID: 10023014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
    Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients.
    D'Ambra MN; Gray RJ; Hillman R; Jones JW; Kim HC; Rawitscher R; Schnaper H; Szymanski I; Vlahakes GJ; Kaplan D; Lynch KE; Guilfoyle M; Abels RI
    Ann Thorac Surg; 1997 Dec; 64(6):1686-93. PubMed ID: 9436556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The usefulness of a computer program Oxygen Status Algorithm (OSA) with particular consideration of oxygen parameters in the Clinic of Chest Diseases].
    Hermanowicz-Salomon J; Dryniec D; Staniszewska K; Droszcz W
    Pol Arch Med Wewn; 1997 Aug; 98(8):122-9. PubMed ID: 9508665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of erythropoietin and its effects on blood lactate and 2, 3-diphosphoglycerate in premature neonates.
    Soubasi V; Kremenopoulos G; Tsantali C; Savopoulou P; Mussafiris C; Dimitriou M
    Biol Neonate; 2000 Nov; 78(4):281-7. PubMed ID: 11093007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.